Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Minerva Surgical, Inc. UTRS
$0.23
-$0 (-1.13%)
На 18:05, 12 мая 2023
+2 073.91%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
37120676.00000000
-
week52high
3.02
-
week52low
0.15
-
Revenue
50294000
-
P/E TTM
-577
-
Beta
0.00000000
-
EPS
-1.22000000
-
Last Dividend
0.00000000
-
Next Earnings Date
02 мая 2023 г. в 20:30
Описание компании
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Piper Sandler | Overweight | Overweight | 10 авг 2022 г. |
| JP Morgan | Underweight | Overweight | 10 авг 2022 г. |
| SVB Leerink | Outperform | Outperform | 12 мая 2022 г. |
| Piper Sandler | Overweight | Overweight | 12 мая 2022 г. |
| Piper Sandler | Overweight | Overweight | 09 мар 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Sung Derrick | A | 86956 | 86956 | 19 июл 2022 г. |
| Behbahani Ali | A | 58279 | 49792 | 10 июн 2022 г. |
| JAFFE ROSS A MD | A | 49792 | 49792 | 10 июн 2022 г. |
| Renzi David | A | 49792 | 49792 | 10 июн 2022 г. |
| Hunt Niquette L. | A | 49792 | 49792 | 10 июн 2022 г. |
| Coste Catherine | A | 129579 | 49792 | 10 июн 2022 г. |
| Anderson Jill | A | 49792 | 49792 | 10 июн 2022 г. |
| Clapper David M | A | 323232 | 229732 | 02 мая 2022 г. |
| Jung Joel R | A | 220730 | 60198 | 02 мая 2022 г. |
| Filloux Dominique J. | A | 266289 | 60198 | 02 мая 2022 г. |
Новостная лента
Minerva Surgical to Present at the 41st Annual J.P. Morgan Healthcare Conference
GlobeNewsWire
03 янв 2023 г. в 16:01
SANTA CLARA, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that its management team will present at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12th at 9:45 a.m. Pacific Time.
Minerva Surgical to Present at the 34th Annual Piper Sandler Healthcare Conference
GlobeNewsWire
21 ноя 2022 г. в 16:01
SANTA CLARA, Calif., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that its management will present at the 34th Annual Piper Sandler Healthcare Conference on Wednesday, November 30, 2022 at 11:00 a.m. Eastern Time in New York City, NY.
Minerva Surgical, Inc. (UTRS) Q3 2022 Earnings Call Transcript
Seeking Alpha
14 ноя 2022 г. в 22:17
Minerva Surgical, Inc. (NASDAQ:UTRS ) Q3 2021 Earning Conference Call November 14, 2022 4:30 PM ET Company Representatives Dave Clapper - President, Chief Executive Officer Joel Jung - Chief Financial Officer Caroline Corner - Investor Relations Conference Call Participants Rohan Raheja - J.P. Morgan Matt O'Brien - Piper Sandler Operator Good day, and welcome to Minerva's Third Quarter 2022 Earnings Call.
Minerva Surgical Announces Change of Date for Third Quarter 2022 Earnings Release and Conference Call
GlobeNewsWire
07 ноя 2022 г. в 16:01
SANTA CLARA, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that it has changed the date of its previously announced earnings conference call. It will now report its third quarter 2022 financial results on Monday, November 14, 2022. In conjunction with the release, the company will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.
Minerva Surgical to Announce Third Quarter 2022 Financial Results
GlobeNewsWire
26 окт 2022 г. в 16:01
SANTA CLARA, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that it will release its third quarter 2022 financial results on Wednesday, November 9, 2022. In conjunction with the release, the company will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.